l centro tecnológico IK4-IDEKO desarrolla el proyecto MIDEMMA, centrado en los procesos de mecanizado ‘sin defectos’ en aplicaciones de micromecanizado, en el que colabora con 17 socios tecnológicos, universidades y empresas europeas.
Este proyecto, liderado por la división de Microtecnología y Ultraprecisión del centro, se encuentra en su recta final. Ya se han completado los trabajos de investigación y desarrollo tecnológico y como resultado se han desarrollado varios demostradores con buenas expectativas para su futura explotación y comercialización.
l centro tecnológico Leartiker está trabajando en el desarrollo del nuevo proyecto MyMat, una spin-off especializada en el desarrollo de materiales más personalizados para dar respuesta a las necesidades de usuarios y fabricantes de impresoras 3D.
Danobatgroup ha lanzado el proyecto TISSKOP, orientado a la tecnología productiva para la fabricación de scaffolds de Medicina Regenerativa, con el objetivo de diversificar su actividad.
a medicina regenerativa es un campo multidisciplinar de investigación que combina los conocimientos de las ciencias de materiales con la biología celular y molecular. Su finalidad es reparar o reemplazar parcial o totalmente el tejido dañado.
La compañía de máquina herramienta ha decidido lanzarse a este campo de actividad porque se trata de un sector que espera tener un importante crecimiento durante los próximos años.
Traditionally, batteries have had few uses in commercial buildings. But a handful of companies are reinventing batteries, making them connected devices that can cut utility bills without an upfront investment.
Santa Clara, CA-based Green Charge Networks said Tuesday it has raised $56 million from K Road DG, a private equity firm focused on distributed energy, to scale up its business. The company intends to expand from operations in New York and California into Texas and Hawaii, a company representative says.
Stripe might be best known for enabling online merchants and websites to process payments more easily, but its team also strongly believes in decentralized payment networks and cryptocurrencies.
Today, Stripe announced that it has invested $3 million into Stellar, which is an open source project, a currency-exchange network, a currency in its own right, and a non-profit. Stellar also launches today.
Stellar, like Bitcoin, is a decentralized payment network and protocol. Unlike Bitcoin, it supports traditional currencies such as U.S. dollars, euros, and so on.
For years the standard operating procedure for the medical device world has been: Bring good tech to patients and be rewarded by the market. Healthcare reform and particularly the consolidation of doctor practices is making this model obsolete. Now the challenge is more along the lines of “Justify your existence.”
Device companies have to revamp the traditional business model to show how their products save money and help patients in the long term.
Une équipe de recherche du département Sciences de la vie de la Faculté des Sciences de la Hong Kong University of Science and Technology [1] a découvert une nouvelle cible moléculaire impliquée dans la maladie d'Alzheimer, ainsi qu'une molécule issue de la pharmacopée traditionnelle chinoise capable d'interagir avec cette cible. Ces découvertes successives majeures, ouvrant de nouvelles perspectives de traitement de cette maladie, ont été publiées dans la revue prestigieuse Proceedings of the National Academy of Sciences of the United States of America (PNAS) [2].
Wth all the cyber-defenses available today — many of them developed in Israel — hackers have to think differently if they want to get through to a high-value target, like a bank, utility, or government site. ThetaRay CEO Mark Gazit says his start-up is dedicated to finding and stopping them.
Since ThetaRay has an effective technology to find these unfindable hackers, investors at General Electric (GE), along with investors at Jerusalem Venture Partners (JVP) and Poalim Capital Markets, among others, are pouring $10 million into ThetaRay, which was established just last year.
A material with optical properties that change to help it capture more incoming sunlight could cut the cost of solar power in half, according to Glint Photonics, a startup recently funded by the Advanced Research Projects Agency for Energy (ARPA-E).
Glint’s adaptive material greatly reduces the cost of a tracking system used in some types of solar power. It changes its reflectivity in response to heat from concentrated sunlight in a way that makes it possible capture light coming in at different angles throughout the day.
When British pharmaceutical giant GlaxoSmithKline announced in October 2012 that it planned to make detailed data from its clinical trials widely available to researchers outside its own walls, the scientific community was stunned. For a company that spends $6.5 billion a year on research and development, it was a sharp turn away from the system of data secrecy that had made it one of the world’s largest drug companies, with 2013 sales of $43.6 billion.
